Aurum Biosciences has develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need.
Aurum Biosciences has raised $928K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2024.
Aurum Biosciences's investors include Scottish Enterprise, TRICAPITAL, InnoScot Health, Scottish Health Innovations, Infinion Biopharma.
Aurum Biosciences is headquartered in Glasgow, United Kingdom.
Aurum Biosciences has develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need.
Aurum Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aurum Biosciences — Funding & Investors." VCBacked, January 24, 2024, https://www.vcbacked.co/company/aurum-biosciences. Accessed September 30, 2026.
VCBacked. (2024). Aurum Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/aurum-biosciences
{{cite web |title=Aurum Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/aurum-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated